SANUWAVE Health, Inc.
SNWV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $32,634 | $20,398 | $16,742 | $13,010 |
| % Growth | 60% | 21.8% | 28.7% | – |
| Cost of Goods Sold | $8,084 | $6,035 | $4,331 | $4,986 |
| Gross Profit | $24,550 | $14,363 | $12,411 | $8,024 |
| % Margin | 75.2% | 70.4% | 74.1% | 61.7% |
| R&D Expenses | $673 | $579 | $567 | $1,101 |
| G&A Expenses | $11,348 | $8,674 | $12,556 | $11,690 |
| SG&A Expenses | $17,671 | $13,572 | $20,030 | $20,281 |
| Sales & Mktg Exp. | $6,323 | $4,898 | $7,474 | $8,591 |
| Other Operating Expenses | $789 | $752 | $766 | $784 |
| Operating Expenses | $19,133 | $14,903 | $21,363 | $22,166 |
| Operating Income | $5,417 | -$540 | -$8,952 | -$14,142 |
| % Margin | 16.6% | -2.6% | -53.5% | -108.7% |
| Other Income/Exp. Net | -$36,762 | -$25,263 | -$1,339 | -$13,089 |
| Pre-Tax Income | -$31,345 | -$25,803 | -$10,291 | -$27,231 |
| Tax Expense | $27 | $4 | $2 | $28 |
| Net Income | -$31,372 | -$25,807 | -$10,293 | -$27,259 |
| % Margin | -96.1% | -126.5% | -61.5% | -209.5% |
| EPS | -7.03 | -12.19 | -7.02 | -19.72 |
| % Growth | 42.3% | -73.6% | 64.4% | – |
| EPS Diluted | -7.03 | -12.19 | -7.02 | -19.72 |
| Weighted Avg Shares Out | 4,463 | 2,117 | 1,465 | 1,382 |
| Weighted Avg Shares Out Dil | 4,463 | 2,117 | 1,465 | 1,382 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $13,637 | $15,623 | $14,132 | $7,095 |
| Depreciation & Amortization | $1,145 | $1,028 | $952 | $1,236 |
| EBITDA | -$16,563 | -$9,152 | $4,793 | -$18,900 |
| % Margin | -50.8% | -44.9% | 28.6% | -145.3% |